Efficacy and tolerance of Algicon in patients with reflux oesophagitis.
Lancaster Smith
M J
MJ
Miller
J P
JP
Whorwell
P J
PJ
D000328:Adult; D000368:Aged; D000464:Alginates / Q000009:adverse effects / Q000627:therapeutic use*; D000536:Aluminum Hydroxide / Q000009:adverse effects / Q000627:therapeutic use*; D000863:Antacids / Q000009:adverse effects / Q000627:therapeutic use*; D001639:Bicarbonates / Q000009:adverse effects / Q000627:therapeutic use*; D002254:Carbonates / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D004942:Esophagitis, Peptic / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged
D000464:Alginates; D000863:Antacids; D001639:Bicarbonates; D002254:Carbonates; C060497:Algicon; D000536:Aluminum Hydroxide